Author Archives: Milly@marketresearchreportstore.com

Abdominal Aortic Aneurysms Global Clinical Trials Review, H1 2017

Summary   Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2017     provides an overview of Abdominal Aortic Aneurysms clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Aortic Aneurysms. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report… Read More »

 

Abdominal Abscess Global Clinical Trials Review, H1 2017

Summary   Abdominal Abscess Global Clinical Trials Review, H1, 2017     provides an overview of Abdominal Abscess clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Abscess. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of… Read More »

 

Pancreatic Cancer Global Clinical Trials Review, H1 2017

Summary   Pancreatic Cancer Global Clinical Trials Review, H1, 2017 ,provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of… Read More »

 

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2016 in Pharmaceuticals

Summary   “Partnerships, Licensing, Investments and M&A Deals and Trends for December 2016 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture… Read More »

 

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer – Global Drug Forecast and Market Analysis to 2025

Summary   Human epidermal growth factor receptor type 2 (HER2-) breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. HER2-negative breast cancer can be subdivided into hormone receptor-positive (HER2-/HR+), and triple negative breast cancer (TNBC). The prognoses of HER2-/HR+ and TNBC differ dramatically, as patients… Read More »

 

Hyperparathyroidism – Opportunity Analysis and Forecasts to 2025

    Summary   Hyperparathyroidism (HPT) is a common endocrinal disorder characterised by excessive plasma levels of parathyroid hormone (PTH) stemming from overactivity of the parathyroid glands. The parathyroid glands, of which there are four, regulate physiological calcium homeostasis through a negative feedback mechanism involving PTH secretion. HPT is classified into either primary, secondary, or… Read More »

 

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan

Summary   CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan    . This report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly,… Read More »